The national drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed/revised the prices in respect of 18 formulation packs both ceiling and retail price packs under Drug Price Control Order (DPCO), 2013.

In a notification dated August 24, 2015, the NPPA has fixed/revised the formulations based on bulk drugs like diclofenac sodium (Superspas – AQ), ilaprazole + domperidone (Chekcid-D SR), albendazole + ivermectin (Albekem Plus), clotrimazole, mesalamine, paracetamol infusion, paracetamol + tramadol HCl (Dolinsta-P), omeprazole + domperidone (Ulcure D), telmisartan + amlodipine(RPTEL-AM), chlorthalidone + metoprolol, vancomycin (Vanking), and diclofenac diethylamine (Diclofenac Transdermal).

The list also includes formulations based on bulk drugs like oxetacaine+aluminium hydroxide+magnesium hydroxide (Pantop OX) and activated dimethicone+magnesium hydroxide+dried aluminium hydroxide+sorbitol(Pantop MPS), oxetacaine +aluminium hydroxide + magnesium hydroxide (Delcid O), fluconazole + sodium chloride, pregabalin+mecobalamin+vitamin B6+folic acid+benfotiamine (Meganeuron PG/ Gabamax Gold), glimepiride + metformin (Zoryl M 0.5 Forte), and corrigendum with regard to notification S.O. No. 619(E) dated February 26,.2015 relating to the ceiling price fixation of paclitaxel injection, 30mg/5ml.

In case the retail price of aforesaid formulation is not complied as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955, the NPPA in its notification warned.